Literature DB >> 8814310

Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development.

J Rantakokko1, H T Aro, M Savontaus, E Vuorio.   

Abstract

We have constructed cDNA clones covering the entire coding region of mouse, human and rabbit preprocathepsin K mRNA for studies on bone turnover. The clone pMCatK-1 for mouse cathepsin K shares 87% nucleotide homology with the corresponding human and rabbit sequences. Analysis of a panel of mouse tissues for tissue distribution of cathepsin K mRNA revealed the highest levels in musculoskeletal tissues: bone, cartilage and skeletal muscle. In situ hybridization of developing mouse embryos was performed to identify the cellular source of cathepsin K mRNA. The strongest mRNA signal was detected in osteoclasts of bone, identified in serial sections by positive TRAP staining. Cathepsin K mRNA was also observed in some hypertrophic chondrocytes of growth cartilages. Association of cathepsin K production with degradation of bone and cartilage matrix suggests that this enzyme and its mRNA levels could serve as markers for matrix degradation in diseases affecting these tissues.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8814310     DOI: 10.1016/0014-5793(96)00907-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

Review 1.  Subtractive hybridization--genetic takeaways and the search for meaning.

Authors:  R J Byers; J A Hoyland; J Dixon; A J Freemont
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

2.  Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix.

Authors:  W Kafienah; D Brömme; D J Buttle; L J Croucher; A P Hollander
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

3.  Manipulating substrate and pH in zymography protocols selectively distinguishes cathepsins K, L, S, and V activity in cells and tissues.

Authors:  Catera L Wilder; Keon-Young Park; Philip M Keegan; Manu O Platt
Journal:  Arch Biochem Biophys       Date:  2011-09-29       Impact factor: 4.013

4.  MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes.

Authors:  T H Vu; J M Shipley; G Bergers; J E Berger; J A Helms; D Hanahan; S D Shapiro; R M Senior; Z Werb
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

5.  Spatiotemporal distribution of heparan sulfate epitopes during murine cartilage growth plate development.

Authors:  Ronald R Gomes; Toin H Van Kuppevelt; Mary C Farach-Carson; Daniel D Carson
Journal:  Histochem Cell Biol       Date:  2006-07-12       Impact factor: 4.304

6.  Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation.

Authors:  M J Jiménez; M Balbín; J M López; J Alvarez; T Komori; C López-Otín
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

Review 7.  Genetic mouse models for bone studies--strengths and limitations.

Authors:  Florent Elefteriou; Xiangli Yang
Journal:  Bone       Date:  2011-08-31       Impact factor: 4.398

8.  Ablation of cathepsin k activity in the young mouse causes hypermineralization of long bone and growth plates.

Authors:  Adele L Boskey; Bruce D Gelb; Eric Pourmand; Valery Kudrashov; Stephen B Doty; Lyudmila Spevak; Mitchell B Schaffler
Journal:  Calcif Tissue Int       Date:  2009-01-27       Impact factor: 4.333

9.  Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.

Authors:  Sutada Lotinun; Riku Kiviranta; Takuma Matsubara; Jorge A Alzate; Lynn Neff; Anja Lüth; Ilpo Koskivirta; Burkhard Kleuser; Jean Vacher; Eero Vuorio; William C Horne; Roland Baron
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

10.  Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis.

Authors:  J P Morko; M Söderström; A-M K Säämänen; H J Salminen; E I Vuorio
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.